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118 A.A. Abdellatif et al.postanesthesia care unit discharge. Patient satisfaction, visual analog scale for intraoperative pain,
and number of patients required rescue fentanyl were recorded. Adverse effects were also recorded.
Results: Surgical ﬁeld bleeding score was signiﬁcantly better in group D compared to group M
(Grade I: 18 vs 4, Grade II: 9 vs 19, Grade III: 0 vs 4, respectively) p< 0.001. Intraoperative
MAP and HR in group D were lower than their baseline values and the corresponding values in
group M. Group M patients were earlier to reach adequate sedation level than those of group
D, but they felt more pain either on local anesthetic injection or during operation. Rescue fentanyl
was needed only for group M patients. Patient satisfaction was higher in group D. Time of surgery
was longer in group M. Both groups were similar in sedation recovery and ward discharge times, as
well as, incidence of side effects.
Conclusion: Compared to midazolam sedation in SMES performed under local anesthesia, Dex-
medetomedine was associated with a near bloodless microscopic surgical ﬁeld, shorter surgery time,
greater patient satisfaction, and lower pain scores with no adverse effects.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Simple Middle Ear Surgeries (SMESs) can be performed under
either local or general anesthesia. Many advantages has been
reported with the local anesthetic techniques, as early recovery,
less postoperative pain, and of great importance the surgeon
ability to test hearing while in surgery. Despite these advanta-
ges, most of SMES are still done under general anesthesia due
to special concerns; some are related to patients’ anxiety which
is augmented in some by their hearing loss, limiting their abil-
ity to cooperate. Other concerns are related to surgeon com-
fortability with the hypotensive general anesthetic
techniques, and the fear of sudden patient movement during
operation [1]. Yung found that most common discomforts that
faced the patients of SMES under local anesthesia were noise
during surgery and anxiety, followed by dizziness, backache,
claustrophobia, and earache [2].
Dexmedetomedine (Dex); is a highly selective a-2 adrenore-
ceptor agonist, which posses both sedative and analgesic actions
[3]. Unlike midazolam, Dex does not depress ventilatory drive
and has shorter elimination half life of 2 h (vs 3–4 h for midazo-
lam) [4]. By attenuating sympathetic activity, it inhibits norepi-
nephrine release and provide a modest reduction in arterial
blood pressure and heart rate [5]; these effects could be advanta-
geous in some surgeries inwhichanear-bloodless ﬁeld is required
to facilitate surgical view and dissection.Dex has been proved as
effective adjunct to general anesthesia to provide deliberate
hypotension in many studies [6–8]. Dex was used to provide
sedation for septoplasty under local anesthesia and proved to
reduce surgical bleeding and gained more patient satisfaction
compared to general anesthetic technique [9]. For sedation in
SMES under local anesthesia, Dex resulted in high surgeon
and patient satisfaction with the method of sedation, but the de-
gree of bleeding in the surgical ﬁeld was not evaluated [7].
So we designed this study to compare the use of Dex as op-
posed to midazolam when used to provide sedation for SMES,
as regards their efﬁcacy to provide a near-bloodless micro-
scopic surgical ﬁeld (primary outcome), hemodynamic and
respiratory effects, patient satisfaction, and recovery charac-
teristics (secondary outcome).2. Methods
Fifty four adult patients (ASA I–II) scheduled for SMES un-
der local anesthesia, were enrolled in this double blind, ran-
domized, comparative clinical trial. Patients were of both
sexes and between 18 and 55 years of age. After gaining the
ethics committee approval from Ain Shams University Hospi-
tals, the study was conducted in the period from October 2010
to August 2011.
Exclusion criteria: Refusal to local anesthesia, impaired
mental status, known allergy to local anesthetics or any of
the study drugs, coagulation disorders, history of cardiac
arrhythmias, sleep apnea, treatment with beta blockers,
chronic use of analgesics, sedatives, alcohol or drug abuse. Pa-
tients were excluded also if operations were redo, the expected
surgery time was more than 2 h, or development of intraoper-
ative severe pain that mandated the conversion to general
anesthesia.
Using the sealed envelope technique, patients were random-
ized to receive intravenous continuous infusion of either Dex
(Group D) or midazolam (Group M). The study scenario
was explained in details in the preoperative visit after which
a written informed consent was obtained from each patient.
We recommended 8 h fasting, no premedications, and urine
voiding within 2 h before operation time.
When the patient arrived to operating room, the operation
site was checked for hair shaving behind the ear, intravenous
18 G cannula was inserted peripherally and a lactated ringer
solution was started at 4 mL/kg/h. A standard monitoring
was applied (non-invasive blood pressure, ECG, pulse oxime-
ter), and a nasal catheter was inserted into one patient nostril
for expired carbon dioxide (CO2) monitoring. Bispectral index
(BIS) monitoring system (BIS VIEW, Aspect Medical Systems,
Inc., Norwood, USA) was used for monitoring the level of
sedation.
2.1. Sedation protocol
As the recommended initial sedation bolus of Dex should be
given over 10 min [10], while that of midazolam over
Table 1 Observer’s Assessment of Alertness/Sedation scale (OAA/S) scale.
Score Responsiveness Speech Facial expression Eyes
5 Responds readily to name spoken in
normal tone
Normal Normal Clear, no ptosis
4 Lethargic response to name spoken in
normal tone
Mild slowing or thickening Mild relaxation Glazed or mild ptosis
3 Responds only after name is spoken
loudly and/or repeatedly
Slurring or prominent slowing Marked relaxation (slack jaw) Glazed and marked ptosis
2 Responds only after mild prodding or
shaking
Few recognized words Marked relaxation (slack jaw) Glazed and marked ptosis
1 Does not respond to mild prodding
or shaking
Few recognized words Marked relaxation (slack jaw) Glazed and marked ptosis
The ﬁnal score is the sum of the responsiveness, speech, facial expression, and eyes component scores. Thus, a ‘‘wide awake’’ score = 5 and a
‘‘deeply sedated’’ score = 1.
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blinding of anesthesia care giver as follows:
A well trained anesthesia resident (un-blinded) was the one
who prepared the drugs as boluses and infusions and he did
not participate in either administration of drugs or collecting
patients’ data. For each group, the bolus and infusion doses
were calculated according to patient weight. Dex bolus dose
was 1 lg/kg diluted in Normal Saline Solution (NSS) and
the starting infusion dose was 0.4 lg/kg/h (range: 0.1–1 lg/
kg/h). Midazolam bolus dose was 0.01–0.03 mg/kg diluted in
NSS, and the starting infusion dose was 0.04 mg/kg/h (range:
0.01–0.1 mg/kg/h).
The bolus dose was given by two successive fully ﬁlled 5 mL
syringes labeled B1 and B2, B1 was injected slowly over
2.5 min while B2 was injected over the next 7.5 min. In group
D: B1 contained 1/4 of the bolus dose and B2 contained the
other 3/4. In group M: B1 contained the whole bolus dose,
while B2 contained only NSS. Fifty mL syringes were used
to prepare the infusion drug; in group D: Dex (Precedex,
Hospira, USA) 200 lg was diluted in NSS to the concentration
of 4 lg/mL, while in group M: midazolam (Dormicum, La
Roche, Switzerland) 20 mg was diluted in NSS to the concen-
tration of 0.4 mg/mL. So according to the used concentration
and dose range of either drug, a starting infusion rate of
0.1 mL/h will be a correct dose for both groups.
By using syringe pump (AJ-5803; Shanghai Angel Elec-
tronic Equipment, China), modiﬁcation of the infusion rate
in a step of 25–50% faster or slower than the initial rate
(and according to the dose range mentioned above) was ti-
trated by the anesthesia care giver to maintain a BIS score be-
tween 70 and 80 throughout the whole surgery.
After sterilization and draping of the patient, oxygen was
allowed to ﬂow under the drapes. Drapes were put over a
low set screen bar opposite to the site of surgeon to improve
patient comfort and allow anesthetist to observe patient’s face.
When a BIS reading of 70–80 was reached (Adequate seda-
tion), the surgeon was allowed to inject local anesthesia using
10–15 ml of lidocaine 2% with adrenaline 1/200,000 to block
auricular and auriculotemporal nerves. The time from start
of bolus drug injection till patient achieve adequate sedation
was recorded. Patients were asked to rate the VRS (Verbal
Rating Scale; 0 = no pain, 10 = maximal pain) for pain on lo-
cal anesthesia injections. Duration of operation was calculated
from the start of local anesthesia injection till skin closure. Thesame surgeon performed all operations. Intraoperatively Mean
Arterial Pressure (MAP) and Heart Rate (HR) were continu-
ously monitored throughout surgery and recorded every
5 min, any episodes of lost CO2 curve (apnea >15 s or
obstruction), or oxygen desaturation (SpO2 < 90%) were
recorded.
Rescue fentanyl bolus 0.5 lg/kg was given if patient was
still complaining of pain or discomfort during operation in-
spite of maintained desired BIS reading, and was allowed to
be repeated once only. Fentanyl boluses were recorded. If
MAP decreased <60 mmHg and HR< 50 beats/min, these
were considered as unwanted hypotension or bradycardia for
which infusion rate was reduced to half of the previous rate
with a ﬂuid bolus of 250 ml given as intravenous push. If
unwanted hypotension or bradycardia did not respond to pre-
vious conservative management, ephedrine 5 mg or atropine
0.5 mg intravenous bolus was used as appropriate. If apnea
or desaturation occurred patient was encouraged to breath,
and the rate of infusion was decreased as before. Any patient
who received ephedrine or atropine, or needed advanced air-
way management for correction of desaturation was excluded
from the study. When the surgeon started to close the skin we
started to assess patient sedation score using Observer’s
Assessment of Alertness and sedation scale (OAA/S) [12] every
5 min and continued in the recovery room (Table 1). Infusion
stopped when surgery was ﬁnished.
After the end of surgery, the surgeon was asked to rate the
bleeding in the surgical ﬁeld according to the 3-grades score
used by Nasreen et al. by the end of operation (Grade I: Blood-
less ﬁeld not hampering surgery, Grade II: mild bleeding
requiring occasional suctioning, and Grade III: excessive
bleeding hampering surgery despite suctioning) [13].
In the postanesthesia care unit (PACU), the time from stop-
page of infusion till the patient reaches OAA/S score of 5 was
recorded as sedation recovery time. MAP and HR were
recorded every 5 min. Patients were discharged to the ward
according to the modiﬁed Aldrete score of P9 [14]. Postoper-
ative nausea and vomiting were recorded and treated with
metoclopramide 10 mg if any.
Just before leaving the PACU, Patients were given a paper
form to rate their satisfaction with the sedation method (as
excellent, good, fair, or poor), and also to rate their intraoper-
ative pain scores by using VAS (Visual Analog Scale; 0 = no
pain, 10 = maximal pain).
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Medcalc version 12.0.3 was used for calculation of the sample
size guided by: a error = 5% (conﬁdence level = 95%), b er-
ror = 5% (power of the test = 95%), and a clinically signiﬁ-
cant difference from 80% to 40% surgical ﬁeld bleeding
score of Grade I. A total sample size of 54 divided into two
equal groups was found to be sufﬁcient to conduct the study.
SPSS (statistical program for social science version 12) was
used for statistical analysis. Quantitative variables were
described as mean and SD while qualitative variables as num-
ber and percentage. Quantitative data were analyzed with
unpaired student t-test, while qualitative data with Chi square
or Fisher’s exact tests as appropriate. P< 0.05 was considered
signiﬁcant, and <0.01 was considered highly signiﬁcant.
3. Results
The two groups were similar regarding data of patients’ char-
acteristics and types of surgery, while duration of surgery was
found to be longer in the M group (p< 0.001) (Table 2).
The surgical ﬁeld bleeding score was superior in group D
compared to group M (p< 0.001). The surgeon observed
Grade I surgical ﬁeld in 18 patients of group D vs only in four
cases in group M. Grade II was observed in nine patients in
group D vs 19 patients in group M. While Grade III was not
observed in any patient in group D, it was observed in four
patients in group M (Table 3).
Patient satisfaction was better in group D (Table 3). The
method of sedation was described as excellent in most of pa-
tients in group D (77.7%) vs 7.4% of patients in group M
(p< 0.001). Poor satisfaction was not reported in group D,
while reported in 25.9% of patients in group M.
Patients in group M felt more pain on local anesthesia
injection than those in group D (VRS: 3.6 ± 0.9 vs
1.5 ± 0.25, respectively). Also, intraoperative pain was moreTable 2 Patients’ characteristics, and measured particular times.
D (n= 27)
Age (years) 31.6 ± 10.8
Weight (kg) 78.5 ± 9
Height (cm) 171.4 ± 9.2
Sex
Male: (n) 18 (66.7%)
Female: (n) 9 (33.3%)
Types of surgery (n)
Tympanoplasty 16 (59.3%)
Mastoedectomy 8 (29.6%)
Stapedectomy 3 (11.1%)
ASA
(I) (n) 15 (55.6%)
(II) (n) 12 (44.4%)
Time for adequate sedation (min) 17.1 ± 4.54
Duration of surgery (min) 69.2 ± 15.75
Time of sedation recovery (min) 15.4 ± 4.88
Time for PACU discharge (min) 35.1 ± 12.5
Data were expressed as mean ± SD, or numbers (%).
t: Student t-test, X2: Chi square test, ASA: American Society of Anesthe
\P< 0.05; statistically signiﬁcant.
** P< 0.01; statistically highly signiﬁcant.in group M compared to group D (VAS: 2.9 ± 0.3 vs
1 ± 0.21, respectively) p< 0.001 (Table 3).
Ten patients in group M required the injection of a single
fentanyl bolus and 7 of them required the injection of the sec-
ond bolus (Table 3), while no patient in group D required the
administration of fentanyl.
In group D the HR values started to be lower from the
baseline at 10 min, while MAP started to be lower from the
baseline at 15 min from the start of sedation. This signiﬁcant
reduction in hemodynamics continued till the end of surgery
and showed signiﬁcant difference from those values recorded
in group M that showed more stable hemodynamics with no
change from the baseline (Fig. 1).
No intraoperative or postoperative adverse effects were re-
ported in group D. In contrast, few patients in group M had
oxygen desaturation, lost capnography wave form, nausea,
and vomiting, while no cases of hypotension or bradycardia
was reported (Table 4). Those patients who had desaturation
or lost capnography, all had responded well to breath encour-
aging and reduction of infusion rate.
Patients in group M achieved adequate sedation level
earlier than those in group D (6.7 ± 2.64 vs 17.1 ± 4.54,
respectively), (p< 0.001). After that, BIS values at the corre-
sponding time points were similar in both groups till the end
of operation (Table 2) (Fig. 2). Furthermore, the times taken
for recovery from sedation and discharge from PACU were
equal in both groups (Table 2).
4. Discussion
Our results demonstrate that Dex sedation for SMES was
associated with signiﬁcantly better surgical ﬁeld bleeding score,
lower HR and MAP values when compared to midazolam
sedation. While midazolam group was earlier to achieve ade-
quate sedation, Dex group was associated with less operation
time, higher patient satisfaction, and lower pain scores. BothM (n= 27) Test value P-value
33.26 ± 11.1 t= 0.557 0.579
80 ± 7.5 t= 0.665 0.508
168.7 ± 10.8 t= 0.989 0.327
16 (59.3%) X2 = 0.079 0.778
11 (40.7%)
18 (66.7%) X2 = 0.953 0.621
5 (18.5%)
4 (14.8%)
17(63%) X2 = 0.077 0.781
10(37%)
6.7 ± 2.64** t= 10.290 <0.001
88.5 ± 19.40** t= 4.013 <0.001
16.8 ± 3.08 t= 1.261 0.213
32.6 ± 11.85 t= 0.754 0.454
siologist.
Table 3 Surgical bleeding score, patient satisfaction score, pain scores and rescue fentanyl boluses.
D (n= 27) M (n= 27) Test value P-value
Surgical ﬁeld bleeding score ** X2 = 16.481 <0.001
Grade I 18 (66.7%) 4 (14.8%)
Grade II 9 (33.3%) 19 (70.4%)
Grade III 0 (0%) 4 (14.8%)
Patient satisfaction score ** X2 = 32.094 <0.001
Excellent 21 (77.8%) 2 (7.4)%
Good 5 (18.5%) 6 (22.2%)
Fair 1 (3.7%) 12 (44.4%)
Poor 0 (0%) 7 (25.9%)
VRS on LA injection 1.5 ± 0.25 3.6 ± 0.90** t= 11.682 <0.001
VAS intraoperative 1 ± 0.21 2.9 ± 0.30** t= 26.960 <0.001
Rescue fentanyl
Single bolus 0 (0%) 10 (37%)** X2 = 9.941 0.001
Two boluses 0 (0%) 7 (25.9%)** X2 = 5.909 0.015
Data are expressed as mean ± SD, or numbers (%).
t: Student t-test, X2: Chi square test, VRS: Verbal Rating Scale, VAS: Visual Analog Scale.
*P< 0.05; statistically signiﬁcant.
** P< 0.01; statistically highly signiﬁcant.
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Figure 1 Intraoperative mean arterial blood pressure and heart
rate values. D: Dexmedetomedine, M: Midazolam, HR: heart rate,
MAP: Mean Arterial Pressure, * statistical difference from the
baseline, and ¥ statistical difference from the other group.
Table 4 Intraoperative and postoperative adverse effects.
D (n= 27) M (n= 27) P
Desaturation SpO2 <90% 0 (0%) 4 (14.8%) 0.110
Lost capnography 0 (0%) 2 (7.4%) 0.490
Hypotension 0 (0%) 0 (0%) –
Bradycardia 0 (0%) 0 (0%) –
Nausea 0(0%) 4 (14.8%) 0.110
Vomiting 0(0%) 1 (3.7%) 0.490
Data are expressed as numbers (%), Fisher’s exact test was used.
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Figure 2 Intraoperative Bispectral Index values. D: Dexmede-
tomedine, M: Midazolam, BIS: Bispectral index, * statistical
difference from the baseline, and ¥ statistical difference from
the other group.
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effects, time for sedation recovery and PACU discharge.
SMES like any other microscopic surgery needs special
anesthetic techniques to provide controlled hypotensive anes-
thesia for better surgical ﬁeld exposure. Many techniques are
being implemented; using volatile anesthetics, beta blockers,
vasodilators, opioids, magnesium and a2 agonists. However,
controlled hypotension is not free of risk; it can lead to tissuehypoxia by lowering autoregulation of vital organ microcircu-
lation. Also it may need the use of invasive blood pressure
monitors, in addition to the adverse effects of speciﬁc drugs
used [1]. a2 agonists were used before as an adjunct to general
anesthesia to provide hypotensive anesthesia; Marchal et al.
premedicated patients with clonidine and reported a signiﬁ-
cantly reduced bleeding, and decreased urapidil requirements
for controlled hypotension [15]. Durmus et al. reported that
Dex was associated with less bleeding, lower anesthetic
122 A.A. Abdellatif et al.requirements, and more hemodynamic stability in response to
anesthesia and surgery in patients undergoing septorhinoplasty
and tympanoplasty under general anesthesia [16].
Dex was used in many settings to provide sedation for oper-
ations performed under local anesthesia. For aesthetic facial
surgery under local anesthesia, Taghinia et al. compared the
addition of Dex infusion to the usual sedative protocol (propo-
fol, midazolam, fentanyl, and ketamine), they reported lower
blood pressure values, but they did not comment on surgical
ﬁeld bleeding. They found that Dex improved the sedation
safety as evidenced by the reported fewer incidences of oxygen
desaturation, and the reduced need for the use of narcotics,
and antiemetics [17]. Their results are consistent with the
results of our study.
On the other hand, Dogan et al. evaluated the surgical
bleeding in septoplasty operations, and found that those per-
formed under local anesthesia with Dex sedation were associ-
ated with signiﬁcantly less bleeding when compared to those
performed under general anesthesia [9].
Dex when compared to midazolam to provide monitored
anesthesia care for cataract surgery, Alhashemi found signiﬁ-
cantly better patient satisfaction scores in Dex group.
Although he reported lower HR and MAP values in Dex
group, he did not ﬁnd any difference in the incidence of hypo-
tension, bradycardia or desaturation between both groups [4].
His previous results match well with the results of our study.
But in contrast to our results, he reported earlier recovery
and discharge times for midazolam group. This difference in
results may be attributed to two factors; ﬁrstly, he used midaz-
olam as a repeat bolus technique while Dex as a continuous
infusion. After an initial bolus of 20 lg/kg of midazolam, he
used repeat boluses of 0.5 mg. According to his reports of
mean total midazolam dose (1.5 mg) and mean body weight
(70.6 kg), we can conclude that many of his patients might
not have needed any repeat bolus. This could have allowed
time for midazolam effect to fade while Dex was continuously
infused in the other group. Secondly, he used Aldrete score of
full 10 points to discharge patients from PACU which; in case
of Dex, might have delayed discharge due to the expected
lower HR or blood pressure values.
When compared to propofol in vitreoretinal surgery under
sub-Tenon’s block, Dex was associated with higher SpO2 val-
ues, better patient satisfaction, lower VAS scores for pain,
while similar surgeon satisfaction, discharge time and equiva-
lent reduction in hemodynamics [18].
In our study, the shorter procedure time found in group D
compared to group M could be explained by the better surgical
bleeding score that might facilitate surgical dissection. Also
some interruption of surgeon work could have happened more
with group M patients either due to pain-related patient move-
ments, or to allow time for rescue fentanyl to alleviate that
pain.
Midazolam sedation in our study was associated with lower
patient satisfaction, higher pain scores and more use of rescue
analgesic. Benedik and Manohin reported similar results when
they compared midazolam during sedation in SMES to propo-
fol, the later provided signiﬁcantly better patient and surgeon
satisfaction scores, earlier recovery times [19]. In another study
by Lee and Lee, the addition of remifentanil to midazolam was
associated with less intraoperative anxiety and greater patient
satisfaction than midazolam alone [20].4.1. Study limitations
One limitation of our study is using BIS for assessment of the
level of sedation. It should be noted that BIS readings depend
on the speciﬁc sedative used. While ketamine paradoxically in-
creases BIS inspite of deep levels of sedation [21], a-2 agonists
decrease it. A study by Kasuya et al. studied the correlation be-
tween BIS and OAA/S during Dex vs propofol sedation [22].
They found that BIS values were lower by 16 points in case
of Dex (62 vs 78) at OAA/S score of 4. To the best of our
knowledge, we could not ﬁnd in the literature that benzodiaze-
pines was comparable to propofol or showed the same differ-
ence from Dex.
Other clinical assessment scores like OAA/S and Ramsay
score are well established widely used scores in clinical prac-
tice. However, they need clinician – patient interaction and this
may lead to awakening of the patients or interrupting the state
of sedation they achieved [22,23], especially when doing assess-
ment every 5 min like in our study. This frequent communica-
tion with the patient may interfere with the surgeon work
especially in microscopic surgeries. Also discrete observations
may fail to detect changes that occur in the sedation level on
every 5 min assessment. The results of our study showed better
patient satisfaction when Dex was used for sedation, if we as-
sume that BIS values were falsely low with Dex, this means it
provided a lighter level of sedation compared to midazolam
and inspite that it leads to better patient satisfaction.
Another limitation is the subjective assessment of the bleed-
ing in the surgical ﬁeld; we used a score used by Nasreen et al.
[13]. Another similar subjective score was used by Turan et al.
[7]. A more objective Doppler ﬂowmetry for the measurement
of middle ear blood ﬂow could have improved the accuracy of
our results, but we did not have the facility to implement it in
our study. We tried to limit the bias of this subjective score by
choosing a single surgeon to perform all the operations.
In conclusion: Dex sedation for SMES appears to be supe-
rior to midazolam in providing less surgical ﬁeld bleeding that
might facilitate surgical exposure and led to shorter operation
time. In addition, it lowered pain scores and improved patient
satisfaction. Although Dex moderately lowered MAP and HR,
no cases of hypotension or bradycardia were reported in our
study.
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